Status:
RECRUITING
Resting State Changes Following Theta Burst Stimulation
Lead Sponsor:
Nicholas Balderston, PhD
Conditions:
Brain Connectivity
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Transcranial magnetic stimulation (TMS) is increasingly being applied to effectively treat mental illness, however efforts to quantify the effects of TMS on the network architecture of the brain have ...
Detailed Description
Transcranial magnetic stimulation (TMS) is currently approved by the FDA for the treatment of depression, obsessive compulsive disorder, and smoking cessation. Despite evidence that TMS improves sympt...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Able to give their consent
- Right-handed
- Exclusion Criteria
- Non-english speaking
- Any significant medical problems
- Current or past Axis I psychiatric disorder(s),
- Active or history of active suicidal ideation
- Alcohol/drug problems in the past year or lifetime alcohol or drug dependence
- Medications that act on the central nervous system
- History of seizure
- History of epilepsy or other neurological problems
- Increased risk of seizure for any reason
- Pregnancy
- Any medical condition that increases risk for fMRI or TMS
- Any metal in their body which would make having an MRI scan unsafe
- Any sort of medical implants
- Claustrophobia
Exclusion
Key Trial Info
Start Date :
November 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05322239
Start Date
November 17 2022
End Date
August 1 2027
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104